Search

Results of the transport properties of the YbNi 1-x Cu x Al (x = 0, 0.2, 0.5, 0.8 and 1.0) series of alloys are reported. The previous analysis of X-ray diffraction patterns indicates that all compounds crystallize in the hexagonal ZrNiAl structure with a linear behavior of the unit cell volume as a function of the Cu concentration (x). This is not found in the unit cell parameters, showing a discontinuity between x = 0.5 and 0.8. Such discontinuities affect the behavior of the electrical resistivity, in which the position of the minimum temperature changes from 95 K to 175 K, and a rise in the low temperature slope in the magnetic contribution (with -lnT dependence) from 21 μΩcm to 212 μΩcm is observed. In addition, the electronic coefficient of the specific heat increases almost twofold from 125 mJ/mol·K 2 (x = 0.5) to 246 mJ/mol·K 2 (x = 0.8). These changes are attributed to the variation of the distance between Yb and transition metals (Ni and Cu) along the series and the different electronic properties of the transition metals (Ni and Cu).

Abstract: Diabetes is a leading cause of peripheral neuropathy (diabetic peripheral neuropathy, DPN), and uncontrolled long-lasting hyperglycemia leads to severe complications. A major proportion of diabetics develop excruciating pain with a variable course. Mechanisms leading to painful DPN are not completely understood and treatment options limited. We hypothesized that epigenetic modulation at the level of microRNA (miRNA) expression triggered by metabolic imbalance and nerve damage regulates the course of pain development. We used clinically relevant preclinical models, genome-wide screening, in silico analyses, cellular assays, miRNA fluorescent in situ hybridization, in vivo molecular manipulations, and behavioral analyses in the current study. We identified miRNAs and their targets that critically impact on nociceptive hypersensitivity in painful DPN. Our analyses identify miR-33 and miR-380 expressed in nociceptive neurons as critical denominators of diabetic pain and miR-124-1 as a mediator of physiological nociception. Our comprehensive analyses on the putative mRNA targets for miR-33 or miR-124-1 identified a set of mRNAs that are regulated after miR-33 or miR-124-1 overexpression in dorsal root ganglia in vivo. Our results shed light on the regulation of DPN pathophysiology and implicate specific miRNAs as novel therapeutic targets for treating painful DPN., (Copyright © 2020 International Association for the Study of Pain.)

Many treatments have been proposed to control epileptic seizures, such as the ketogenic diet and caloric restriction. However, seizure control has not yet been improved completely in all patients. Probably, due to the lack of understanding regarding this neurological disorder pathogenesis or pathophysiology, including its molecular approach. Currently, there is not much information about the molecular processes and genes involved, and their relation to the possible beneficial effects of diet therapy on epilepsy. The ketogenic diet and caloric restriction are implicated in potential anti-seizure mechanisms related to the gut microbiome, metabolic pathways, hormones and neurotransmitters, mitochondria improvement, a role in inflammation, and oxidative stress, among others. In this review, we pretend to describe the molecular mechanism and the possible genes involved in the different ketogenic diet and caloric restriction mechanisms of action described to decrease neural excitability and, therefore, epileptic seizures, especially when conventional treatment is not enough to achieve control of epilepsy., (Copyright © 2020 Elsevier B.V. All rights reserved.)